4L9M.A | RASGRP1

General Structure Information 4l9m RASGRP1 autoinhibited state of the ras-specific exchange factor rasgrp1 3.0Å AUTH J.S.IWIG,Y.VERCOULEN,R.DAS,T.BARROS,A.LIMNANDER,Y.CHE,AUTH 2 J.G.PELTON,D.E.WEMMER,J.P.ROOSE,J.KURIYANTITL STRUCTURAL ANALYSIS OF AUTOINHIBITION IN THE RAS-SPECIFICTITL 2 EXCHANGE FACTOR RASGRP1.REF ELIFE V. 2 00813 2013REFN ESSN 2050-084XPMID 23908768DOI 10.7554/ELIFE.00813 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants

See Details
1X2Q.A | STAM2

General Structure Information 1x2q STAM2 solution structure of the sh3 domain of the signal transducing adaptor molecule 2 -1.0Å AUTH E.CHIKAYAMA,T.KIGAWA,M.SATO,S.KOSHIBA,M.INOUE,AUTH 2 S.YOKOYAMATITL SOLUTION STRUCTURE OF THE SH3 DOMAIN OF THE SIGNALTITL 2 TRANSDUCING ADAPTOR MOLECULE 2REF TO BE PUBLISHEDREFN Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants

See Details
3KFQ.A | CTSV

General Structure Information 3kfq CTSV unreduced cathepsin v in complex with stefin a 1.99Å AUTH M.RENKO,D.TURKTITL UNREDUCED CATHEPSIN V IN COMPLEX WITH STEFIN AREF TO BE PUBLISHEDREFN Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants

See Details
4BC5.B | XYLB

General Structure Information 4bc5 XYLB crystal structure of human d-xylulokinase in complex with inhibitor 5-deoxy-5-fluoro-d-xylulose 1.98Å AUTH R.D.BUNKER,E.M.M.BULLOCH,J.M.J.DICKSON,K.M.LOOMES,E.N.BAKERTITL STRUCTURE AND FUNCTION OF HUMAN XYLULOKINASE, AN ENZYMETITL 2 WITH IMPORTANT ROLES IN CARBOHYDRATE METABOLISMREF J.BIOL.CHEM. V. 288 1643 2013REFN ISSN 0021-9258PMID 23179721DOI 10.1074/JBC.M112.427997 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis […]

See Details
3KXO.A | HPGDS

General Structure Information 3kxo HPGDS an orally active inhibitor bound at the active site of hpgds 2.1Å AUTH C.P.CARRON,J.I.TRUJILLO,K.L.OLSON,W.HUANG,B.C.HAMPER,T.DICE,AUTH 2 B.E.NEAL,M.J.PELC,J.DAY,D.C.ROHRER,J.R.KIEFER,J.B.MOON,AUTH 3 B.A.SCHWEITZER,T.D.BLAKE,S.R.TURNER,R.WOERNDLE,B.L.CASE,AUTH 4 C.P.BONO,V.M.DILWORTH,C.L.FUNCKES-SHIPPY,B.L.HOOD,AUTH 5 G.M.JEROME,C.M.KORNMEIER,M.R.RADABAUGH,M.L.WILLIAMS,AUTH 6 M.S.DAVIES,C.D.WEGNER,D.J.WELSCH,W.M.ABRAHAM,C.J.WARREN,AUTH 7 M.E.DOWTY,F.HUA,A.ZUTSHI,J.Z.YANG,A.THORARENSENTITL DISCOVERY OF AN ORAL POTENT SELECTIVE INHIBITOR OFTITL 2 HEMATOPOIETIC PROSTAGLANDIN D SYNTHASEREF TO BE PUBLISHEDREFN Variant Set Distributions Ripley’s K Analysis Plots Variant […]

See Details
4L6Q.A | ROCK2

General Structure Information 4l6q ROCK2 rock2 in complex with benzoxaborole 2.79Å AUTH T.AKAMA,C.DONG,C.VIRTUCIO,D.SULLIVAN,Y.ZHOU,Y.K.ZHANG,AUTH 2 F.ROCK,Y.FREUND,L.LIU,W.BU,A.WU,X.Q.FAN,K.JARNAGINTITL LINKING PHENOTYPE TO KINASE: IDENTIFICATION OF A NOVELTITL 2 BENZOXABOROLE HINGE-BINDING MOTIF FOR KINASE INHIBITION ANDTITL 3 DEVELOPMENT OF HIGH-POTENCY RHO KINASE INHIBITORS.REF J.PHARMACOL.EXP.THER. V. 347 615 2013REFN ISSN 0022-3565PMID 24049062DOI 10.1124/JPET.113.207662 Variant Set Distributions Ripley’s K Analysis Plots Variant […]

See Details
3AP1.B | TPST2

General Structure Information 3ap1 TPST2 crystal structure of human tyrosylprotein sulfotransferase-2 complexed with pap and c4 peptide 1.9Å AUTH T.TERAMOTO,Y.FUJIKAWA,Y.KAWAGUCHI,K.KUROGI,M.SOEJIMA,AUTH 2 R.ADACHI,Y.NAKANISHI,E.MISHIRO-SATO,M.C.LIU,Y.SAKAKIBARA,AUTH 3 M.SUIKO,M.KIMURA,Y.KAKUTATITL CRYSTAL STRUCTURE OF HUMAN TYROSYLPROTEIN SULFOTRANSFERASE-2TITL 2 REVEALS THE MECHANISM OF PROTEIN TYROSINE SULFATIONTITL 3 REACTION.REF NAT COMMUN V. 4 1572 2013REFN ESSN 2041-1723PMID 23481380DOI 10.1038/NCOMMS2593 Variant Set Distributions Ripley’s K […]

See Details
4F91.B | SNRNP200

General Structure Information 4f91 SNRNP200 brr2 helicase region 2.7Å AUTH K.F.SANTOS,S.M.JOVIN,G.WEBER,V.PENA,R.LUHRMANN,M.C.WAHLTITL STRUCTURAL BASIS FOR FUNCTIONAL COOPERATION BETWEEN TANDEMTITL 2 HELICASE CASSETTES IN BRR2-MEDIATED REMODELING OF THETITL 3 SPLICEOSOME.REF PROC.NATL.ACAD.SCI.USA V. 109 17418 2012REFN ISSN 0027-8424PMID 23045696DOI 10.1073/PNAS.1208098109 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants

See Details
2I3Y.A | GPX5

General Structure Information 2i3y GPX5 crystal structure of human glutathione peroxidase 5 2.0Å AUTH K.L.KAVANAGH,U.OPPERMANNTITL CRYSTAL STRUCTURE OF HUMAN GLUTATHIONE PEROXIDASE 5REF TO BE PUBLISHEDREFN Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants

See Details
1WRY.A | SH3BGRL

General Structure Information 1wry SH3BGRL solution structure of the sh3 domain-binding glutamic acid- rich-like protein -1.0Å AUTH K.INOUE,K.MIYAMOTO,T.NAGASHIMA,F.HAYASHI,T.KIGAWA,AUTH 2 S.YOKOYAMATITL SOLUTION STRUCTURE OF THE SH3 DOMAIN-BINDINGTITL 2 GLUTAMIC ACID-RICH-LIKE PROTEINREF TO BE PUBLISHEDREFN Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants

See Details